Why the study?
Differentiating constrictive pericarditis (CP) from restrictive cardiomyopathy (RCM) is challenging because both share a common presentation of predominantly right-sided heart failure due to impaired ventricular diastolic filling. However, distinguishing these two conditions is critical because CP is potentially curable while therapeutic options for RCM are limited.
This review outlines the pathophysiology, hemodynamics, diagnostic assessment, and therapeutic approach needed to critically distinguish between potentially curable constrictive pericarditis and restrictive cardiomyopathy.
Differentiation of constrictive pericarditis (CP) from restrictive cardiomyopathy (RCM) is a complex and often challenging process. Because CP is a potentially curable cause of heart failure and therapeutic options for RCM are limited, distinction of these 2 conditions is critical. Although different in regard to etiology, prognosis, and treatment, CP and RCM share a common clinical presentation of predominantly right-sided heart failure, in the absence of significant left ventricular systolic dysfunction or valve disease, due to impaired ventricular diastolic filling. Fundamental to the diagnosis of either condition is a clear understanding of the underlying hemodynamic principles and pathophysiology. We present a contemporary review of the pathophysiology, hemodynamics, diagnostic assessment, and therapeutic approach to patients presenting with CP and RCM.
No takes yet. Share an insight, caveat, or question.
Geske et al. (2016) conducted a review in Constrictive pericarditis and restrictive cardiomyopathy. Diagnostic assessment of hemodynamic principles and pathophysiology was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: